LambdaGen Therapeutics envisions development of next-generation personalized stem-cell based therapeutics using its proprietary non-viral genome insertion system based on λ-integrase system.
Our versatile platform allows insertion of large fragments of DNA at specific site in the human genome which empowers us to propel our R&D efforts to develop innovative therapeutic solutions for a spectrum of genetic diseases and cancer immunotherapy.
Company Details
- Employees
- 2
- Founded
- 2019
- Address
- 2 Havelock Road, Singapore,singapore
- Industry
- Biotechnology
- Keywords
- genome editing, site-specific insertion, gene therapy, cancer immunotherapy, stem cells, regenerative medicine, lambda-integrase, genome engineering, rare genetic diseases.
- HQ
- Singapore
Lambdagen Pte. Ltd. Questions
Lambdagen Pte. Ltd.'s website is http://www.lambdagentherapeutics.com
Lambdagen Pte. Ltd.'s LinkedIn profile is https://sg.linkedin.com/company/lambdagen
Lambdagen Pte. Ltd. has
2 employees.
View email and phone details for 2
employees at Lambdagen Pte. Ltd..
Lambdagen Pte. Ltd.'s industry is
Biotechnology
Lambdagen Pte. Ltd.'s top competitors are
Rnascence Biotechnology Www.biorna.sg,
Cantabio Pharmaceuticals, Inc.,
Co11ab Novena,
Satya Pharma Innovations Private Limited,
Wasna,
Satya Pharmaceuticals Ayurveda,
Anthem Biosciences Limited,
Ramja Genosensor,
Neodocs (Yc S21),
Singzyme.
Lambdagen Pte. Ltd.'s categories are Biotechnology
Lambdagen Pte. Ltd.'s founding year is 2019
